Literature DB >> 12163884

[Quality of life in systemic lupus erythematosus]

S. Rinaldi1, A. Doria, F. Vescovi, S. Corbanese, L. Iaccarino, S. Della Libera, G. Perini, P. F. Gambari.   

Abstract

The SF-20 and the SF-36 are the most frequently used questionnaires for assessing the quality of life in SLE patients. The SF-36 is actually considered the most suitable for this disease, due to the inclusion of fatigue, a manifestation frequently observed in SLE patients. Using these instruments, it has been clearly demonstrated that patients with SLE have a worse quality of life than healthy people of the same age. Some aspects of daily life, like physical activity, job, social relationship and vitality, are particularly affected. In the majority of studies, an inverse relation between quality of life and disease activity has been observed. The influence the damage has on the quality of life is more complex, since a greater number of variables are involved. In fact, the amount of damage largely depends on the organ involved and on functional impairment resulting from it. To explain the variability in the quality of life among different patients, it is important to consider, besides the clinical complaints, the psycho-social dimension of each person. In fact, some SLE patients, unlike others, cope well with the disease. People behave differently when faced with critical situations, i.e. after being diagnosed with a chronic disease; their reaction depends on the degree of support they receive from family, friends and colleagues, and from the different strategies of coping, that they use.

Entities:  

Year:  2001        PMID: 12163884     DOI: 10.4081/reumatismo.2001.108

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  1 in total

1.  Psychological distress and quality of life are improved in autoimmune patients through Tandem-Psychotherapy, combining individual hypnosis and eye movement desensitization and reprocessing (EMDR) treatment for trauma, followed by supportive-expressive group therapy.

Authors:  Maria Teresa Corsetti; Edoardo Rossi; Sofia Bonvino; Pietro Randazzo
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.